Most TP53 mutations in cancer cells, including gain-of-function (GOF) mutations (such as R248Q, R273H, and R175H), result in single amino acid substitutions in the DNA binding domain of the encoded protein (p53)17. This evidence concerns the gene TP53 and cancer.